These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 9820628)
1. Comparison of rhG--CSF primed bone marrow and blood stem cell autografts: an analysis of engraftment in malignant lymphomas and solid tumours. Knudsen LM; Hansen SW; Daugård G; Jarlbaek L; Agerbaek M; Jensen L; Skovsgård T; Hansen F; Johnsen HE Eur J Haematol; 1998 Oct; 61(4):229-34. PubMed ID: 9820628 [TBL] [Abstract][Full Text] [Related]
2. High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells. Nademanee A; Sniecinski I; Schmidt GM; Dagis AC; O'Donnell MR; Snyder DS; Parker PM; Stein AS; Smith EP; Molina A J Clin Oncol; 1994 Oct; 12(10):2176-86. PubMed ID: 7523609 [TBL] [Abstract][Full Text] [Related]
3. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia. Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100 [TBL] [Abstract][Full Text] [Related]
4. Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells. Morton J; Hutchins C; Durrant S Blood; 2001 Dec; 98(12):3186-91. PubMed ID: 11719353 [TBL] [Abstract][Full Text] [Related]
5. Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF. Weisdorf D; Miller J; Verfaillie C; Burns L; Wagner J; Blazar B; Davies S; Miller W; Hannan P; Steinbuch M; Ramsay N; McGlave P Biol Blood Marrow Transplant; 1997 Oct; 3(4):217-23. PubMed ID: 9360784 [TBL] [Abstract][Full Text] [Related]
6. Hemopoietic stem-cell harvesting and transplantation using G-CSF-primed BM: comparison with unprimed BM and G-CSF-primed PBSC. Lowenthal RM; Tuck D; Tegg E; Marsden KA; Rees B; Luck J; Ragg S; Parker N; Kotlovsky N Cytotherapy; 1999; 1(5):409-16. PubMed ID: 20426541 [TBL] [Abstract][Full Text] [Related]
7. Characterization of CD34+ peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor. Tjønnfjord GE; Steen R; Evensen SA; Thorsby E; Egeland T Blood; 1994 Oct; 84(8):2795-801. PubMed ID: 7522643 [TBL] [Abstract][Full Text] [Related]
8. Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony-stimulating factor (rhG-CSF): a randomized evaluation of different doses of rhG-CSF. Demirer T; Ayli M; Ozcan M; Gunel N; Haznedar R; Dagli M; Fen T; Genc Y; Dincer S; Arslan O; Gürman G; Demirer S; Ozet G; Uysal A; Konuk N; Ilhan O; Koc H; Akan H Br J Haematol; 2002 Feb; 116(2):468-74. PubMed ID: 11841454 [TBL] [Abstract][Full Text] [Related]
9. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases]. Chen Y; Huang X; Xu L; Liu D; Zhang Y; Ren H; Guo N; Lu D Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1306-9. PubMed ID: 12509932 [TBL] [Abstract][Full Text] [Related]
10. Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor. Watanabe H; Watanabe T; Suzuya H; Wakata Y; Kaneko M; Onishi T; Okamoto Y; Abe T; Kawano Y; Kagami S; Takaue Y Bone Marrow Transplant; 2006 Apr; 37(7):661-8. PubMed ID: 16489358 [TBL] [Abstract][Full Text] [Related]
11. Peripheral blood stem cell (PBSC) mobilization and transplantation (PSCT) in patients with malignant lymphomas and solid tumors. Richel DJ; Van der Wall E; Slaper J; Van der Schoot E; Rodenhuis S Int J Artif Organs; 1993 Dec; 16 Suppl 5():71-5. PubMed ID: 7516919 [TBL] [Abstract][Full Text] [Related]
13. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. Bensinger WI; Clift R; Martin P; Appelbaum FR; Demirer T; Gooley T; Lilleby K; Rowley S; Sanders J; Storb R; Buckner CD Blood; 1996 Oct; 88(7):2794-800. PubMed ID: 8839878 [TBL] [Abstract][Full Text] [Related]
14. Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation. Singhal S; Powles R; Kulkarni S; Treleaven J; Sirohi B; Millar B; Shepherd V; Saso R; Rowland A; Long S; Cabral S; Horton C; Mehta J Bone Marrow Transplant; 2000 Mar; 25(5):501-5. PubMed ID: 10713626 [TBL] [Abstract][Full Text] [Related]
15. Randomized trial of autologous filgrastim-primed bone marrow transplantation versus filgrastim-mobilized peripheral blood stem cell transplantation in lymphoma patients. Damiani D; Fanin R; Silvestri F; Grimaz S; Infanti L; Geromin A; Cerno M; Michieli M; Rinaldi C; Savignano C; Trani G; Fiacchini M; Baccarani M Blood; 1997 Jul; 90(1):36-42. PubMed ID: 9207435 [TBL] [Abstract][Full Text] [Related]
16. Peripheral blood stem cell transplantation from unrelated donors: a comparison with marrow transplantation. Ringdén O; Remberger M; Runde V; Bornhäuser M; Blau IW; Basara N; Hölig K; Beelen DW; Hägglund H; Basu O; Ehninger G; Fauser AA Blood; 1999 Jul; 94(2):455-64. PubMed ID: 10397713 [TBL] [Abstract][Full Text] [Related]
17. Granulocyte colony-stimulating factor-primed bone marrow: an excellent stem-cell source for transplantation in acute myelocytic leukemia and chronic myelocytic leukemia. Li Y; Jiang M; Xu C; Chen J; Li B; Wang J; Hu J; Ning H; Chen H; Chen S; Hu L Chin Med J (Engl); 2015 Jan; 128(1):20-4. PubMed ID: 25563308 [TBL] [Abstract][Full Text] [Related]
18. Improved retroviral gene transfer into murine and Rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor. Dunbar CE; Seidel NE; Doren S; Sellers S; Cline AP; Metzger ME; Agricola BA; Donahue RE; Bodine DM Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11871-6. PubMed ID: 8876230 [TBL] [Abstract][Full Text] [Related]
19. Autologous transplantation with peripheral blood stem cells collected after granulocyte colony-stimulating factor in patients with acute myelogenous leukemia. Demirer T; Petersen FB; Bensinger WI; Appelbaum FR; Fefer A; Rowley S; Sanders J; Chauncey T; Storb R; Lilleby K; Buckner CD Bone Marrow Transplant; 1996 Jul; 18(1):29-34. PubMed ID: 8831992 [TBL] [Abstract][Full Text] [Related]
20. Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte-colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit-GM, engraftment, and Day +100 hematopoietic graft function. Alexander ET; Towery JA; Miller AN; Kramer C; Hogan KR; Squires JE; Stuart RK; Costa LJ Transfusion; 2011 Sep; 51(9):1995-2000. PubMed ID: 21392017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]